ArticleInternational dental journal2026
The Effect of miR-129-5p on the Proliferation and Osteogenic Differentiation of Human Dental Pulp Stem Cells.
Article in International dental journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo investigate the role of microRNA-129-5p (miR-129-5p) in the proliferation and osteogenic differentiation of human dental pulp stem cells (hDPSCs). MATERIALS AND
methodsDifferential expression analysis was performed using the GEO dataset GSE138180 to identify differentially expressed genes during the osteogenic differentiation of hDPSCs. Primary hDPSCs were isolated and cultured using the tissue block method combined with enzymatic digestion, and their stemness was characterized by alizarin red staining, oil red O staining, and flow cytometry. The expression dynamics of miR-129-5p at different stages of osteogenic induction were detected by quantitative real-time PCR (qRT-PCR). hDPSCs were transiently transfected with miR-129-5p mimic, negative control (mimic-NC), miR-129-5p inhibitor, or negative control (inhibitor-NC), and the transfection efficiency was verified by qRT-PCR. Cell proliferation was assessed by the CCK-8 assay. The expression of osteogenic-related genes (alkaline phosphatase [ALP], collagen type I [COL1], runt-related transcription factor 2 runt [RUNX2]) and proteins (ALP, osteopontin [OPN]) was measured using qRT-PCR, immunofluorescence, and Western blot, while mineral deposition was evaluated by alizarin red and alkaline phosphatase staining.
resultsDifferential expression analysis revealed that miR-129-5p expression was significantly downregulated after 14 days of osteogenic induction compared with the control group. The primary cultured cells formed mineralized nodules and lipid droplets, were positive for CD90 and CD73, and were negative for CD45 and CD34. The expression of miR-129-5p continued to decrease after 7 and 14 days of osteogenic induction. Overexpression of miR-129-5p suppressed hDPSC proliferation, downregulated the expression of ALP, COL1, RUNX2, and OPN, and reduced mineral deposition. Conversely, inhibition of miR-129-5p promoted cell proliferation, enhanced the expression of osteogenic-related genes and proteins, and increased mineral deposition.
conclusionInhibition of miR-129-5p promotes the proliferation and osteogenic differentiation of hDPSCs, suggesting that reduced miR-129-5p expression is associated with enhanced osteogenic potential and may have implications for pulp tissue engineering. CLINICAL RELEVANCE: This study investigated how miR-129-5p modulates the proliferation and osteogenic differentiation of hDPSCs. The findings elucidate its potential role in the regeneration of the pulp-dentin complex and indicate its therapeutic potential for dental tissue repair.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.